Background
Intergraph Corporation owned patents covering aspects of its Clipper microprocessor architecture — a RISC-based design that had been originally developed at Fairchild Semiconductor. When Fairchild’s semiconductor division was acquired by National Semiconductor, the Clipper patents were assigned directly from Fairchild to Intergraph; they never passed through National Semiconductor’s ownership. National Semiconductor and Intel had entered into a cross-license agreement covering patents owned by or licensed to National Semiconductor.
Intel later asserted that its cross-license with National Semiconductor extended to Intergraph’s Clipper patents. Intel’s theory was that the Clipper patents had some relationship to the Fairchild-to-National chain of corporate transactions and that National had sufficient involvement with or control over these patents for the cross-license to attach. The district court accepted Intel’s argument and granted summary judgment that Intel was licensed under the Intergraph Clipper patents. Intergraph appealed.
The Court’s Holding
The Federal Circuit reversed, holding that Intel’s cross-license with National Semiconductor did not extend to Intergraph’s Clipper patents. Writing for the court, Judge Newman explained that a cross-license covers patents that the licensor owns or controls — it cannot extend to patents that were never part of the licensor’s portfolio. The Clipper patents moved directly from Fairchild to Intergraph through a direct assignment; National Semiconductor never owned them, never licensed them, and had no authority to grant anyone else rights under them.
The court applied general principles of license construction: license grants are interpreted according to what the licensor actually had the right to grant. A party cannot license what it does not own. Intel could not claim the benefit of a National Semiconductor cross-license for patents that National Semiconductor had no relationship to. The fact that corporate transactions occurred in the same industry at roughly the same time — and that Fairchild had relationships with both National and Intergraph — did not mean that National had constructive ownership or control over patents directly assigned to Intergraph.
Key Takeaways
- A cross-license agreement only covers patents that the licensor owns or legitimately controls — it cannot extend to patents that passed to a third party through a direct assignment that bypassed the licensor entirely.
- Patent ownership chains must be carefully traced in corporate transactions: a party cannot grant rights to patents it never held, regardless of general industry consolidation or related corporate activity.
- Cross-license agreements should expressly define their scope — including whether they cover only patents currently owned, future-acquired patents, or patents related to particular technology lines — to avoid ambiguity in later disputes.
- Corporate patent transfers in semiconductor and technology M&A require careful documentation of exactly which patents transfer to which entity, especially when transactions involve multiple affiliated companies.
- This decision was part of a broader Intergraph v. Intel litigation campaign in which Intergraph sought to enforce its Clipper patents against multiple chipmakers.
Why It Matters
Intergraph v. Intel is a practical guide to reading the scope of cross-license agreements in technology company transactions. Cross-licenses are common tools for managing patent risk in industries with overlapping patent portfolios — semiconductor companies, in particular, frequently cross-license broad portfolios to avoid litigation over foundational component patents. But the scope of a cross-license depends entirely on what the licensor actually owned and had authority to grant rights to.
This decision matters for any company involved in mergers, acquisitions, or corporate spin-offs involving patent portfolios. If a patent is assigned directly to an acquiring party without ever passing through an intermediate entity’s ownership, cross-licenses granted by that intermediate entity cannot reach the assigned patent. Deal lawyers and patent counsel must carefully map patent assignments when negotiating cross-licenses and should not assume that related corporate transactions create implied licensing relationships between all parties in a corporate family.